14-30586733-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_017769.5(G2E3):c.53G>A(p.Arg18Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000381 in 1,368,432 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017769.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
G2E3 | NM_017769.5 | c.53G>A | p.Arg18Gln | missense_variant | 3/15 | ENST00000206595.11 | NP_060239.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
G2E3 | ENST00000206595.11 | c.53G>A | p.Arg18Gln | missense_variant | 3/15 | 1 | NM_017769.5 | ENSP00000206595.6 |
Frequencies
GnomAD3 genomes AF: 0.000172 AC: 26AN: 151596Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000107 AC: 21AN: 195908Hom.: 0 AF XY: 0.000102 AC XY: 11AN XY: 107858
GnomAD4 exome AF: 0.000407 AC: 495AN: 1216836Hom.: 0 Cov.: 17 AF XY: 0.000386 AC XY: 236AN XY: 611902
GnomAD4 genome AF: 0.000172 AC: 26AN: 151596Hom.: 0 Cov.: 32 AF XY: 0.000149 AC XY: 11AN XY: 74012
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2023 | The c.53G>A (p.R18Q) alteration is located in exon 3 (coding exon 2) of the G2E3 gene. This alteration results from a G to A substitution at nucleotide position 53, causing the arginine (R) at amino acid position 18 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at